Actualités Pfizer - PFE

Les meilleurs offres pour accéder les cours en temps réel en illimité
Real-time Level 1 for Canada + USA
Abonnement Mensuel
Seulement
32,99 €
Trader
Abonnement Mensuel
Seulement
34,09 €
Expert
Abonnement Mensuel
Seulement
92,39 €
Prix hors taxes
Nom Action Symbole Action Marché Type
Pfizer Inc PFE NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Plus Haut Plus Bas Ouverture Clôture Veille Dernier échange
  0,00 0,0% 36,34 0,00 0,00 0,00 36,34 12:25:47
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/10/201901:58DJNHealth-Care Stocks Get a Welcome Respite -- Update
15/10/201918:56DJNHealth-Care Stocks Get a Welcome Respite
15/10/201916:22DJNElizabeth Warren's Rise Is Battering Health-Care Stocks
15/10/201914:29DJNElizabeth Warren's Rise Is Battering Health-Care Stocks
14/10/201908:00PRNUSImaginAb signs multi-party collaboration agreement with..
12/10/201910:45BWPfizer Presents Positive Phase 3 Data at the 28th Congress..
10/10/201923:41EDGARStatement of Changes in Beneficial Ownership (4)
10/10/201923:41EDGARStatement of Changes in Beneficial Ownership (4)
10/10/201923:41EDGARStatement of Changes in Beneficial Ownership (4)
10/10/201923:41EDGARStatement of Changes in Beneficial Ownership (4)
07/10/201916:12DJNAkcea Therapeutics Shares Up 44% on Pfizer Licensing..
07/10/201912:50GLOBEAkcea and Pfizer Inc. Announce Licensing Agreement for..
01/10/201923:48EDGARStatement of Changes in Beneficial Ownership (4)
01/10/201923:48EDGARStatement of Changes in Beneficial Ownership (4)
01/10/201923:48EDGARStatement of Changes in Beneficial Ownership (4)
01/10/201923:48EDGARStatement of Changes in Beneficial Ownership (4)
01/10/201922:20EDGARStatement of Changes in Beneficial Ownership (4)
01/10/201922:20EDGARStatement of Changes in Beneficial Ownership (4)
01/10/201922:20EDGARStatement of Changes in Beneficial Ownership (4)
01/10/201922:19EDGARStatement of Changes in Beneficial Ownership (4)
01/10/201901:55DJN4D Molecular Therapeutics Files for IPO, Applies to List on..
30/9/201908:30BWPfizer Presents Interim Analysis Results from Phase 3 BEACON..
27/9/201923:47DJNCorrection to Pfizer CEO Headline
27/9/201921:32DJFRPfizer: Albert Bourla va succéder à Ian Read au poste de..
27/9/201919:16DJNPfizer CEO Albert Bourla to Succeed Ian Read as..
27/9/201917:38EDGARCurrent Report Filing (8-k)
27/9/201916:24DJNPfizer CEO Albert Bourla to Succeed Ian Read as..
27/9/201915:26DJNStocks to Watch: Wells Fargo, Bank of New York Mellon,..
27/9/201915:00BWPfizer Inc. Awards “Golden Tickets” to Neutrolis and Mediar..
27/9/201914:59DJNPfizer CEO Albert Bourla to Succeed Ian Reed as Chairman
27/9/201914:00BWIan Read to Retire as Executive Chairman of Pfizer’s Board..
27/9/201913:26DJNPfizer Sees Positive Top-Line Results for Atopic Dermatitis..
27/9/201912:45BWPfizer Announces Positive Top-Line Results from Second..
24/9/201916:19BWPfizer Declares Fourth-Quarter 2019 Dividend
24/9/201914:00BWPfizer Presents New Evidence of IBRANCE® (palbociclib)..
24/9/201913:10DJNBioNTech SE Sees IPO Range of $18-$20/ADS
20/9/201914:56DJNMerck KGaA, Pfizer Get CHMP Positive Opinion for Bavencio
19/9/201913:38BWPfizer Presents Scientific Advancements in Cancer Care at..
17/9/201916:00BWPfizer Invites Public to View and Listen to Webcast of..
16/9/201922:34EDGARStatement of Changes in Beneficial Ownership (4)
16/9/201922:34EDGARStatement of Changes in Beneficial Ownership (4)
16/9/201922:34EDGARStatement of Changes in Beneficial Ownership (4)
16/9/201922:34EDGARStatement of Changes in Beneficial Ownership (4)
13/9/201914:26DJNBiopharmaceutical Company Imara Inc. Files Confidentially..
13/9/201901:07DJNSpringWorks Therapeutics IPO Prices at High End of Range
12/9/201914:21DJNSpringWorks Raises IPO to 9 Million Shares at $16-$18 Each
10/9/201922:53EDGARFiling of Certain Prospectuses and Communications in..
09/9/201915:11DJNPfizer: Positive Preliminary Phase 2 Results for 20-Valent..
09/9/201914:00BWPfizer Announces Positive Preliminary Results from a..
04/9/201922:39EDGARFiling of Certain Prospectuses and Communications in..
Voir d'autres actualités liées à cette action »
Dernières Valeurs Consultées
NYSE
PFE
Pfizer
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Conditions Générales

P: V: D:20191017 10:42:50